2 Followers USX:SUPN - Supernus Pharmaceuticals, Inc SUPERNUS PHARMACEUTICALS INC
Sector: Health Care, Industry: Pharmaceuticals
Next Earnings: 16 Aug 2021
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 31.2    -0.630 (-1.98%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

11 Jun 2021


Loading...
Loading...
Loading...

General

CEO: Mr. Jack A. Khattar

IPO: 2012-05-01

Headquarters: US

Employees: 563

Homepage

Description

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The company products include Oxtellar XR, Trokendi XR, SPN-812, and others. The majority of the revenue is generated from the sale of Trokendi XR.